HIV/AIDS
Research from Spain and Netherlands in HIV/AIDS provides new insights
Published in AIDS Weekly, May 22nd, 2006
Study 1: HAART initiation after severe immunosuppression has occurred is detrimental for the restoration of the CD4+ cell counts in vertically infected children.
"Several studies of children with human immunodeficiency virus (HIV) type 1 infection have demonstrated sustained increases in CD4+ cell count, even when virological failure has occurred after receipt of highly active antiretroviral therapy (HAART), but these studies were of limited duration. Moreover, the CD4+ cell count threshold at which antiretroviral treatment should be initiated is still unsettled. The aim of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-05-22)
More Articles from AIDS Weekly
- HIV/AIDS Drug Development
HIV-1 replication inhibited by artificial transcription factors targeting primer binding site - HIV/AIDS Drug Monitoring
Intraindividual variability in HAART levels limit therapeutic drug monitoring utility - HIV/AIDS Genetics & Genomics
Chromosome 2 carries a gene required for production of infectious HIV-1 - HIV/AIDS Immune Response
Pneumococcal vaccine immunogenicity in HIV/AIDS not altered by vitamin A or zinc supplement - HIV/AIDS-Related Encephalitis
Alcohol abuse enhances neuroinflammation and impairs immune response in HIV encephalitis - Awards
Philadelphia AIDS Consortium recognizes community organizations at providers' awards event - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
